{"database": "lobbying", "table": "lobbying_activities", "rows": [[1181301, "83600c6e-dee9-49fd-9d2f-4cb5c61667a0", "Q4", "HOLLAND & KNIGHT LLP", 18466, "SHIRE PHARMACEUTICALS, INC", 2011, "fourth_quarter", "HCR", "Prepare advocacy materials to be used for lobbying on issues related to development of drugs for rare diseases, reimbursement of products, and FDA review and approval of products for rare diseases and other conditions. Prepared materials regarding S. 296, Preserving Access to Life Saving Medicines Act; Met with congressional staff regarding same shortage legislation.  Developed advocacy materials re: HR 3737 \"Unlocking Live Saving Rare Diseases Act.", "Agency for Healthcare Research & Quality (AHRQ),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE", 40000, null, 0, 0, "2012-01-03T13:32:52-05:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["1181301"], "units": {}, "query_ms": 56.274464121088386, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}